27th July 2015
Minister for Jobs, Enterprise and Innovation today announced that PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, is opening a new global decision-making hub for the Company in Kilmainham, Dublin 8. PAREXEL plans to hire an additional 130 people over the next 12 to 18 months across all areas of their business – clinical, technology, legal, consulting, and logistics – and at all levels, including senior decision-making roles in their Kilmainham location. Seventy employees are in place, and recruitment is underway for the new positions.
The investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
Making the announcement Minister for Jobs, Enterprise and Innovation Richard Bruton TD said: “Life sciences is a key sector which we have targeted as part of our Action Plan for Jobs, and in recent years we have seen an impressive jobs performance in this area, both in Dublin and across the country. Today’s announcement that PAREXEL is adding 130 jobs in Kilmainham is a great boost and an example of the wide range of different types of jobs that Ireland can attract in this sector. I look forward to working closely with Douglas and the team at PAREXEL as they roll out this project.”
“Europe is important to our growth and business strategy, and Ireland specifically is a key country from which we can better serve our customers and continue our growth,” said Douglas A. Batt, Senior Vice President and General Counsel, PAREXEL. “This office will be a global decision-making hub for our Company. Senior leaders based here will be making strategic decisions for the Company worldwide, and this office will play a critical role in continuing to bring PAREXEL’s global brand to the world.”
Welcoming PAREXEL’s decision to locate this strategically important part of its global business in Ireland, Martin Shanahan, CEO, IDA Ireland said: PAREXEL’s decision to locate in Ireland is an endorsement of the skills available to biopharmaceutical companies here. Ireland is the perfect place in which to locate a Global Hub – our location facilitates access into Europe, the Middle East and further afield. IDA Ireland has targeted the Life Sciences, and in particular, the Biopharmaceuticals sector for several years now – PAREXEL will be joining a very large cluster of biopharma companies that have already chosen Ireland as a place to locate business.
About IDA Ireland
The IDA is Ireland’s inward investment promotion agency. It is a non-commercial, semi-state body promoting foreign direct investment in Ireland through a wide range of services. The IDA partners with potential and existing investors to help them establish or expand their operations in Ireland.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics, Inc. provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 80 locations in 51 countries around the world, and had approximately 17,440 employees in the third quarter. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.
Cristi Barnett Cristi.Barnett@PAREXEL.com +1-781-254-7246 or +1-781-434-4019
For IDA Ireland:
Kevin Sammon Kevin.Sammon@ida.ie +353876188564
Back to Department News